What was amended
The federal government has registered the National Health (Minimum Stockholding) Amendment Determination (No. 2) 2026. This instrument amends the National Health (Minimum Stockholding) Determination 2023, which sets rules about minimum stock levels for certain health products.
The amendment was registered on 25 February 2026. The changes contained in Schedule 1 commence on 1 March 2026.
Administering framework
The instrument is administered by the Department of Health, Disability and Ageing under the National Health Act 1953.
What the source does not specify
The source summary does not specify which products or stock levels are affected by the Schedule 1 amendments, nor does it detail what changed from the previous determination.
Key actions
- Parties who supply, distribute, or store pharmaceutical or health products under the National Health (Minimum Stockholding) Determination 2023 are required to check whether the Schedule 1 amendments affect minimum stock obligations from 1 March 2026 - the full determination is available at https://www.legislation.gov.au/F2026L00156
- The Department of Health, Disability and Ageing is the contact point for clarification on which products or categories are covered by the amended stockholding rules.
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.